Cargando…

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis

Purpose: To perform a multi-institutional analysis following treatment of limited osseous and/or nodal metastases in patients using a novel hypofractionated image-guided radiotherapy with simultaneous-integrated boost (HIGRT-SIB) technique. Methods: Consecutive patients treated with HIGRT-SIB for ≤5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Corbin D., Palta, Manisha, Williamson, Hannah, Price, Jeremy G., Czito, Brian G., Salama, Joseph K., Moravan, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558188/ https://www.ncbi.nlm.nih.gov/pubmed/31214509 http://dx.doi.org/10.3389/fonc.2019.00469

Ejemplares similares

Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis
por: Shenker, Rachel F., et al.
Publicado: (2022)

Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers
por: Jacobs, Corbin D., et al.
Publicado: (2020)

Deep Learning–Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost
por: Wang, Wentao, et al.
Publicado: (2021)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

A current perspective on stereotactic body radiation therapy for pancreatic cancer
por: Hong, Julian C, et al.
Publicado: (2016)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
por: Jorgo, Kliton, et al.
Publicado: (2019)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery
por: Unterkirhere, Olga, et al.
Publicado: (2023)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020)

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience
por: Zhong, Liangzhi, et al.
Publicado: (2019)

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
por: Beaudry, M.M., et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
por: Pontoriero, Antonio, et al.
Publicado: (2020)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
por: Schmitt, Martin, et al.
Publicado: (2022)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach
por: Märtens, Bettina, et al.
Publicado: (2012)

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
por: Gregucci, Fabiana, et al.
Publicado: (2021)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
por: Pfaffendorf, Charlotte, et al.
Publicado: (2022)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
por: Barbour, Andrew B., et al.
Publicado: (2019)

Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases
por: Jiang, Aijun, et al.
Publicado: (2019)

Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases
por: Ni, Lingqin, et al.
Publicado: (2014)

Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting
por: Elson, Andrew, et al.
Publicado: (2015)

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
por: Ciammella, Patrizia, et al.
Publicado: (2013)

Radiation Therapy for Palliation of Sarcoma Metastases: A Unique and Uniform Hypofractionation Experience
por: Soyfer, Viacheslav, et al.
Publicado: (2010)

A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases
por: Rodrigues, George, et al.
Publicado: (2012)

Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
por: Osman, Sarah O. S., et al.
Publicado: (2022)

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
por: Shi, Zhan, et al.
Publicado: (2022)

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality
por: Akgun, Zuleyha, et al.
Publicado: (2023)

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial
por: Ricco, Anthony, et al.
Publicado: (2020)

Whole‐brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non‐small cell lung cancer: A single‐institution study
por: Qing, Dong, et al.
Publicado: (2019)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery
por: Yu, Ting, et al.
Publicado: (2021)

Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation Therapy
por: Wijetunga, Asanka R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nrpdq9r7svmekjebpg968pd7u2